For Research Partners
Ncology™ is working with a select group of neuro-oncology key opinion leaders on protocol feasibility intelligence. Conversations are confidential. NDAs available upon request.
Protocol eligibility criteria are designed months — sometimes years — before a single patient is approached. The assumptions embedded in that design are rarely tested against how patients actually move through care. The result: screen failure rates in neuro-oncology trials that consistently exceed 50%, enrollment timelines that slip, and protocol amendments that arrive too late.
Ncology™ is building the data infrastructure to change that — grounded in 20+ years of front-line neuro-oncology experience and insights from 50+ clinical trials.
Pain Points by Role
Sponsors
Enrollment delays and high screen failure rates start at protocol design. We help you stress-test eligibility criteria against real-world patient trajectories before a single site is activated.
CROs
Site feasibility assessments tell you how many patients a site has seen. They don't tell you how many will actually qualify. Ncology™ adds the layer that's been missing.
KOLs and Investigators
Protocol design decisions made early have eligibility consequences that surface late. We bring the patient-level insight that bridges clinical intent and enrollment reality.
Request a conversation
This is not a public product. We are selectively partnering with research teams who are serious about solving the enrollment problem in neuro-oncology. If that’s you, we’d like to have a conversation.